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Abstract 
Objective: This preliminary study aims to determine the differentially expressed proteins from 
chondrogenic differentiated multipotent stromal cells (cMSCs) in comparison to undifferentiated 
multipotent stromal cells (MSCs) and adult chondrocytes (ACs).  
Methods: ACs and bone marrow-derived MSCs were harvested from New Zealand White 
rabbits (n = 3). ACs and cMSCs were embedded in alginate and were cultured using a defined 
chondrogenic medium containing transforming growth factor-beta 3 (TGF-β3). Chondrogenic 
expression was determined using type-II collagen, Safranin-O staining and glycosaminoglycan 
analyses. Two-dimensional gel electrophoresis (2-DE) was used to isolate proteins from MSCs, 
cMSCs and ACs before being identified using liquid chromatography-mass spectrometry (LC-MS). 
The differentially expressed proteins were then analyzed using image analysis software.  
Results: Both cMSCs and ACs were positively stained with type-II collagen and safranin-O. The 
expression of glycosaminoglycan in cMSCs was comparable to AC at which the highest level was 
observed at day-21 (p>0.05). Six protein spots were found to be most differentially expressed 
between MSCs, cMSCs and ACs. The protein spots cofilin-1 (CFL1) and glycealde-
hyde-3-phosphate dehydrogenase (GAPD) from cMSCs had expression levels similar to that of 
ACs whereas the others (ie. MYL6B, ALDOA, TAGLN2, EF1-alpha), did not match the expression 
level of ACs.  
Conclusion: Despite having similar phenotypic expressions to ACs, cMSCs expressed proteins 
which were not typically expected. This may explain the reason for the unexplained lack of im-
provement in cartilage repair outcomes reported in previous studies. 
Key words: 2D gel electrophoresis, Chondrocytes, Chondrogenic multipotent stromal cells, Chon-
drogenesis, LC-MS, Multipotent mesenchymal stem cells, Protein expression, orthopaedics 
Introduction 
In vivo and in vitro cell-mediated cartilage re-
generation has been extensively studied in both hu-
man and animal models. It has been demonstrated 
that when articular cartilage defects regenerate, they 
form mainly fibro-cartilaginous tissue, which has in-
ferior biochemical and biomechanical properties as 
compared to hyaline cartilage [1]. It has been men-
tioned that the development of fibrocartilage tissue 
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can be attenuated if the appropriate cartilage proteins 
are expressed. It is therefore believed that further 
improvement to the cartilage repair outcomes can be 
achieved by ensuring that the appropriate proteins, 
which may also involve the proteins predominantly 
found in hyaline matrix, are expressed within the re-
paired cartilage site. One way to ensure that this is 
achieved is through the implantation of cells that have 
the ability to express the typical proteins required to 
obtain optimal tissue repair. The effect of implanting 
these cells has been observed in many studies and is 
presently being used as acceptable therapies in many 
countries [2]. In most studies, the use of autologous 
chondrocyte is common [3]. However, the use of these 
cells appears to only provide good medium-term 
outcomes attributed to the ageing transplanted cells, 
which is expected of any adult somatic cells [1].  
Multipotent stromal cells (MSCs) are regarded as 
a promising and potential alternative cell source in the 
repair of cartilage due to its multi-lineage differentia-
tion ability in vitro. Although MSCs possess strong 
intrinsic chondrogenic capacity, implantation of un-
differentiated MSCs in constructs using various 
sources has also resulted in the formation of fibrous 
tissues, increased expression of type-I collagen and 
the loss of sulphated glycosaminoglycan (sGAG) 
content [4]. Furthermore, bone marrow MSCs showed 
an increased propensity to express type-X collagen 
which correlates with mineralization of the tissue at 
the implanted site [4]. It has therefore been postulated 
that the use of pre-differentiated chondrogenic MSCs 
in vitro would have the ability to express specific car-
tilage related proteins, which can lead to early if not 
better cartilage healing. However, in our previous 
pre-clinical study, we were not able to demonstrate 
the superiority of cMSCs over MSCs [5].  
The reason for our previous finding remains 
unexplained. Although cMSCs may produce expres-
sions that are closely similar to adult chondrocytes 
(AC), within the mixture of proteins expressed there 
may be alterations or deviations in the protein ex-
pression patterns, which lead to the limitations in the 
final outcome observed previously. When attempts 
were made to determine if such phenomenon may be 
the case, it is found that previous studies were mainly 
confined to determining the differential protein ex-
pression of pre- and post-chondrogenic induction of 
MSCs. Furthermore, reports comparing cMSCs to ACs 
appear lacking [6-8]. Considering that the under-
standing of such findings holds great importance for 
the development of future therapies, this proteomic 
study was therefore conducted to compare the global 
protein expression of cMSCs to that of ACs and MSCs.  
Materials and Methods 
Cell and tissue Culture  
This study was approved by the University of 
Malaya animal ethics committee [OS/05/07/2006/ 
TKZ/A(R) and OS/02/06/2008/TKZ(a)(R)]. Primary 
ACs and bone marrow MSCs were collected sepa-
rately from three male New Zealand white rabbits 
(age: 3 months old; weight: 2.0 ± 0.5 kg). Animals were 
sacrificed by overdosing animals with CO2 gas prior 
to sample harvesting. 
ACs were aseptically isolated from cartilage tis-
sues as described by Ab-Rahim et. al. (2008)[9]. The 
specimens were finely minced using surgical blade 
before being digested in 0.6% type-II collagenase 
(Worthington Biochemical Corporation, Lakewood, 
NJ, USA) at 37°C for 14 hours. This was followed by a 
centrifugation at 500 g for 10 minutes before the cell 
pellet was being seeded at 100,000 cell/cm2 in 
DMEM/Ham’s F-12 Nutrient Mixture (1:1) supple-
mented with 10% fetal bovine serum (FBS), 0.0025% 
ascorbic acid and 1% penicillin-streptomycin (PS) 
(Gibco, USA). The cells were then incubated at 37°C in 
a humidified atmosphere containing 5% CO2. After 14 
days, the cultured cells were used at passage 2 for cell 
differentiation assay.  
MSCs were cultured as described by Boo et. al. 
(2011)[10]. Briefly, 2 mL of bone marrow was diluted 
with Phosphate buffered saline (PBS) solution (1:2) 
before being loaded onto 3 mL Ficoll-paque (GE 
Healthcare-Amersham Biosciences, Piscataway, NJ). 
Mononuclear cells were then harvested from the in-
terface of plasma and Ficoll-paque after being centri-
fuged at 500g for 25 minutes. The cells were cultured 
for 14 days in DMEM containing 10% FBS and 1% PS 
at 37°C in a humidified incubator containing 5% CO2... 
Characterization of ACs and MSCs  
AC cultures were characterized using monoclo-
nal anti-collagen Type-II (Calbiochem, Merck Milli-
pore, MA, USA); monoclonal anti-collagen Type-I 
Rabbit (Calbiochem, Merck Millipore, MA, USA) and 
histological staining of Safranin-O (Sigma-Aldrich Co, 
USA). MSC cultures were identified through immu-
no-cytochemistry analysis by determining the surface 
CD markers: CD29 (Chemicon, Merck Millipore, MA, 
USA); CD44 (GeneTex, Irvine, CA, USA) and CD45 
(GeneTex, Irvine, CA, USA).MSC were induced into 
adipogenic and osteogenic lineage using STEMPRO® 
adipogenesis and osteogenesis differentiation kits 
(Gibco), respectively. The cultures were then stained 
with oil red O (adipogenic cultures) and Alizarin Red 
S (osteogenic cultures) after 14 days. 
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Chondrogenic differentiation of MSC and AC 
in Alginate three-dimensional (3D) culture  
MSC- and AC-alginate beads were prepared 
using a 1.2% low viscosity alginate solution (Sig-
ma-Aldrich) mixed in 0.15M sodium chloride as pre-
viously described [11]. MSC and AC-alginate beads 
were then formed in a 102 mM calcium chloride solu-
tion at a density of 4 × 106 cells/mL. Alginate beads 
were then washed with 0.15M sodium chloride. Ten 
cell-alginate constructs were transferred to each well 
of a 6-well culture plate (Corning, USA) before being 
cultured in chondrogenic defined medium (Lonza, 
Walkersville, MD USA) containing 10 ng/mL TGF-β3 
(Lonza, USA). MSC and AC-alginate cultures were 
maintained at 37oC in a humidified environment 
containing 5% CO2 for 21 days. 
Histology and immunohistochemistry  
This experiment was performed according to the 
instructions described in DAKO Cytomation EnVision 
+ System HRP kit (DAKO, Denmark). MSC- and 
AC-alginate beads were fixed in 10% paraformalde-
hyde for 20 minutes, followed by serial dehydrations 
(70% ethanol for 15 minutes, 95% ethanol for 30 
minutes, 100% ethanol for 30 minutes) and xylene (20 
minutes). Samples were embedded in paraffin, sec-
tioned (5-µm thickness) and stained with monoclonal 
anti-collagen type-II (Calbiochem, Merck Millipore, 
MA, USA) and Safranin-O.  
Glycosaminoglycan (GAG) analysis  
GAG content of the culture supernatant of MSC, 
cMSC and AC groups was performed using Blyscan 
glycosaminoglycan assay kit (Biocolor Ltd, Co An-
trim, UK). Briefly, the aliquot of each sample was 
mixed with DMMB dye and reagents (Biocolor) ac-
cording to the manufacturer’s instructions. The ab-
sorbance was measured at 656 nm using nanopho-
tometer (Implen, München, Germany). Values from 
GAG analysis were normalized to the protein content 
(ng GAG/µg protein). 
Protein extraction of MSC- and AC-alginate 
beads  
Alginate constructs were solubilized in 55mM 
sodium citrate solution (Sigma-Aldrich) as described 
previously [11]. The dissolved alginate beads were 
centrifuged at 300 g for 10 minutes. The MSC and ACs 
were then lysed in 2-D Protein Extraction Buffer (GE 
Healthcare, USA) containing urea and NP-40 and 
protease inhibitors (Roche Diagnostics GmbH, Ger-
many) for 1 hour using shaker at room temperature. 
Cell lysate was centrifuged at 15000 g for 10 minutes 
at 4°C. Protein concentration was quantified using 
BCA Protein Assay Kit (Pierce, Thermo Scientific, 
Rockfold, IL USA). 
Isoelectric focusing (IEF) and Two-dimensional 
Gel Electrophoresis (2-DE)  
Prior to IEF, cell lysate was precipitated in ace-
tone. Immobiline DryStrips (24cm, pH 3-10, GE 
Healthcare-Amersham Biosciences, NJ) were rehy-
drated with 100 µg of protein, in 450 µL of solubiliza-
tion solution. IEF was conducted using the IPGphor 
IEF System (GE Healthcare, USA) via rehydration for 
18 hours at room temperature, 1 hour at 500 V, 1 hour 
at 1000 V and 8 hours at 8000 V, resulting in a total of 
75 000 V hour. The gel strips were equilibrated in two 
steps of 15 minutes each with gentle agitation. The 
first equilibration solution contained 1% DTT. In the 
second equilibration solution, the DTT was replaced 
with 1.5% iodoacetamide. After equilibration, the IPG 
strips were rinsed gently with ddH2O, followed by a 
blotting to remove excess equilibration buffer. The 
IPG strips were then transferred onto 12.5% 
SDS-PAGE gels before being overlaid with 0.5% aga-
rose. 2-D SDS-PAGE was conducted at 100 V for 1 
hour and 400 V for 7 hours using the Ettan DALT 
twelve system (GE Healthcare, USA). The proteins 
were stained using a silver-staining method as de-
scribed by Chevallet et. al. (2006)[12]. 
Silver-stained gels were scanned using UMAX 
Powerlook 1120USG image scanner (GE Healthcare, 
USA) at a resolution of 300 dpi. Spot detection, quan-
tification and matching were performed using Pro-
genesis SameSpots software according to the manu-
facturer’s instructions (Nonlinear Inc., NC, USA). 
Three individual gel replicates from each group were 
used in the analysis.  
Protein Identification using Liquid 
Chromatography MS/MS (LC-MS/MS)  
Identification of protein spots were performed 
through liquid chromatography mass spectrometry. 
Protein samples were extracted according to the 
standard techniques described previously [13]. The 
peptides were analysed using electrospray ionisation 
mass spectrometry (Dionex, Thermoscientific, CA, 
USA) coupled to a 4000 QTRAP mass spectrometer 
(Applied Biosystems). The peptides were loaded onto 
a C18 PepMap100, 3 µm (LC Packings, Dionex, 
Thermoscientific, CA, USA) before being separated by 
a linear gradient of water/acetonitrile/0.1% formic 
acid (v/v).  
Database Search  
The amino acid sequence tags obtained from 
each peptide fragmentation in LC-MS analyses were 
used to search for protein candidates using Mascot 
online sequence matching software (Matrix Science, 
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London, UK; www.matrixscience.com). The searches 
for peptide mass fingerprints were performed against 
rodent taxonomy in the LudwigNR database (305,368 
entries; last updated on 20 September 2012). Variable 
modifications included were oxidation of methionine, 
allowing up to one missed cleavage site. The search 
parameters are as follows: peptide tolerance ± 1.2 Da; 
MS/MS tolerance ± 0.6 Da; peptide charge +1, +2 or 
+3; monoisotopic mass value. Identification was ac-
cepted as positive when a minimum of two matching 
peptides and more than 10% of the peptide coverage 
sequences have matched. Probability scores were sig-
nificant at p<0.05 for all matches. 
Statistical Analyses  
Statistical analyses were performed using Statis-
tical package for the social sciences (SPSS) software 
(version 17.0, SPSS Inc, Chicago, USA). The values of 
sGAG concentrations were presented as mean ± SD. 
Comparisons of variables between the two groups 
were analyzed using parametric independent 
pair-wise student t-test. Differences were considered 
statistically significant at p<0.05. 2-DE gels were ana-
lyzed using Progenesis SameSpots software version 
4.4 (Nonlinear Inc., NC, USA). Differentially ex-
pressed proteins were documented as mean of nor-
malized log volume ± standard error (SE). Parametric 
statistical analysis using ANOVA test was also per-
formed to determine the statistical significance of the 
results. Statistically significant differences were re-
garded at p<0.01. The power of current study was 
88.5% calculated using Progenesis SameSpots soft-
ware.  
In order to avoid false positive discovery, all the 
six differentially expressed protein spots (p<0.01) 
were further subjected to false discovery rate test be-
fore being confirmed by q-value <0.01. 
Results 
Morphological observation and 
Immunophenotyping of MSCs and ACs 
Bone marrow MSCs appeared as fibroblastic and 
spindle-shaped (Figure 1A). The cultured MSCs were 
positive for the presence of surface markers CD44 and 
CD29 but not CD45 (Figure 1A, B, C). However, the 
ACs exhibited an amoeboid and squamous-shaped 
cells in the monolayer culture (Figure 1D) with only 
type-II collagen and proteoglycan expression (Figure 
1D, E, F). MSCs and ACs displayed spherical-shaped 
morphology in 3D culture. Upon reaching 21 days of 
culture in chondrogenic medium, MSC and 
AC-alginate beads expressed proteoglycan and 
type-II collagen as observed from the histological 
analysis. 
MSCs cultured in adipogenic medium for 14 
days have developed intracellular lipid droplets, 
identified by Oil Red O analysis (Figure 2A). After 14 
days in osteogenic culture medium, the MSCs have 
secreted a mineralized matrix, which was character-
ized by Alizarin Red staining (Figure 2B).  
 
 
  
Figure 1: Immunophenotyping of MSCs and ACs. MSCs expressed cell surface markers CD29 (1A) and CD44 (1B). CD45 was absent in MSCs (C). AC 
showed the expression of ECM: type-II collagen (1D) and proteoglycan (1E) secretions. Type-I collagen was absence in the AC monolayer culture (1F). 
(Magnification: 100X in 1A, B, C, D and F; 200X in 1E). 
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Figure 2: Histochemical analyses of adipogenic and osteogenic capacities of MSCs. MSCs were cultured in (2A) adipogenic medium and (2B) osteogenic 
medium for 14 days. The cultures were stained with Oil Red O for validation of intracellular lipid (2A; magnification 100X) and with Alizarin Red S for 
mineralized matrix (2B; magnification 100X). 
 
Figure 3: Representative histological appearance of chondrogenic culture. MSC (3A and 3B) and AC-alginate constructs (3C and 3D) were stained with 
type-II collagen (3A and 3C) and safranin O (3B and 3D) at day-21. ECM of both MSC-alginate and AC-pellet constructs were present with type-II collagen 
(3A and 3C; magnification 400X) and proteoglycan (3B and 3D; magnification 400X). 
 
Histology and Immunohistochemical staining 
of cell-constructs 
Chondrogenic MSC-alginate beads (Figure 3A, 
B) and AC-alginate construct (Figure 3C, D) expressed 
type-II collagen (Figure 3A, C) and proteoglycan 
(Figure 3B, D).  
Biochemical GAG assay 
Secretion of GAG by cMSC cultures was signifi-
cantly elevated from day-0 with the highest level ob-
served at day-21 (p<0.01), which is about ten times 
more than day-0 (Figure 4). However, the deposition 
of GAG declined at day-28 (83.94 ± 4.83 ng 
GAG/µg/mL protein). No significant difference was 
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found between the GAG amount at day-21 and day-28 
(p>0.05). In general, ACs secreted GAG at a slower 
pace than cMSCs. However, AC doubled its GAG 
secretion at day-14 (65.42 ± 0.57 ng GAG/µg/mL 
protein) as compared to day-0 (14.85 ± 0.38 ng 
GAG/µg/mL protein), and the highest being ob-
served at day-21(107.55 ± 6.28 ng GAG/µg/mL pro-
tein). At day-28, GAG secretion by ACs declined to 
91.25 ± 4.82 ng GAG/µg/mL protein. In addition, 
secreted GAG from cMSC and ACs did not differ 
between day-21 and day-28 (p>0.05).  
 
 
Figure 4: GAG secretion of MSC, cMSC and AC culture from day-0 to 
day-28 were compared to their respective control using parametric 
2-sided independent t-test. GAG secretion in both cMSC and AC was 
significantly higher than MSC (p<0.01). GAG secretion of cMSC was 
significantly enhanced at day-21 compared to day-0 (p<0.01). 
 
Principal component analysis 
Principal components analysis was used to de-
termine the homogeneity in the protein profiles of 
MSC, cMSC and AC. Proteomic maps were utilized as 
“score graphs” for variables and spots from the dif-
ferent groups. Figure 5 shows that MSC spots (ma-
genta) were close to each other and were situated on 
one side of the graph, while AC spots (violet) were 
clustered on the opposite side. Spots corresponding to 
the cMSC were situated and clustered between these 
positions. These results indicate that our data were 
homogenous with no outlier data affecting the statis-
tical analysis. 
Proteome Changes in chondrogenic induced 
MSCs 
About 1050 spots were detected using 2-DE 
analyses (p<0.01). From the 1050 spots, 146 protein 
spots were classified as differentially expressed based 
on the computer-assisted 2-DE gel differential analy-
sis. Of these, six highly modulated proteins were ex-
cised from the preparative gels for mass spectrometry 
(MS) analysis. The positions and the densitometry 
analysis of the six protein spots were labelled on the 
2-DE gels (Figure 6) and data obtained presented in 
Table 1.  
Protein Identification by LC-MS Analysis 
The identified proteins were classified into four 
groups, namely cytoskeleton related protein (CFL1 
and MYL6B), metabolic enzymes (GAPD and 
ALDOA), cell proliferation (TAGLN2) and protein 
biosynthesis (EF1-ALPHA) as annotated in Table 2. 
 
Table 1: Densitometry assessment of identified differentially 
expressed protein spots.  
Spot No. Log Normalized Spot Volume Contribution (Mean ± 
SE) 
MSC cMSC AC 
7436 7.89 ± 0.09 7.68 ± 0.16 7.50 ± 0.26 
6433 6.99 ± 0.13 7.51 ± 0.36 8.08 ± 0.12 
4410 6.12 ± 0.18 6.61 ± 0.39 6.94 ± 0.37 
3657 7.58 ± 0.09 7.13 ± 0.08 7.33 ± 0.05 
5416 7.56 ± 0.20 6.86 ± 0.28 7.39 ± 0.12 
4203 7.60 ± 0.08 6.87 ± 0.31 7.42 ± 0.14 
Experiments were repeated at least three times (n=3) under identical conditions 
and using cells from different animals (N=3). 
 
 
 
 
 
Figure 5: Principal component analysis of 2-DE gel electrophoresis data. Scores graphs combining proteomic maps (variables) and spots from different 
groups (observations) were constructed. Principal components analysis clustered the nine silver-stained expression maps into three different groups. 
Principal component 1 was 48.37% from the modulated proteins and principal component 2 was 42.84% from the modulated proteins. Color dots rep-
resent sample group: MSC (magenta), cMSC (blue) and AC (violet). 
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Table 2: Differentially expressed proteins identified by LC-MS.  
Spot 
No. (a) 
Gene Name Protein Name Mascot 
Score (b) 
Swiss Prot. 
accession no. (c) 
Mr  
(d) 
pI (e) 
 
Sequence 
Coverage (%) 
(f) 
Peptide 
Matches 
(g)  
Cellular Function  
(h) 
7436 CFL1  Cofilin-1 (Fr) 
 
59 H0VBH0 18521 8.22 15 2 Cytoskeleton related 
protein 
 6433 MYL6B  
 
Myosin light chain 6B  
 
77 G3HRQ5 22778 5.40 11 6 
5416 TAGL N2 Transgelin-2 isoform (Fr) 79 H0W7H0 22441 8.60 13 3 
4410 GAPD  Glyceraldehyde-3-phosphate de-
hydrogenase (Fr) 
57 Q8K417 30811 8.57 28 15 Metabolic enzymes 
3657 ALDOA  Fructose-biphosphate aldolase  83 H0VA39 39382 8.30 15 4 
4203 EF1-ALPHA  Elongation factor 1-alpha 87 H0V2B3 50109 9.10 11 8 Protein biosynthesis  
 
(a) Spot numbers referred to the numbers shown in Figure 6; (b) MASCOT score; (c) accession number on the SwissProt database; (d) Mr referred to theoretical molecular 
mass; (e) pI referred to theoretical Isoelectric point of the protein; (f) sequence coverage (%) meant sequence coverage in percentage searched by MASCOT; (g) peptide 
matches referred to the number of matched peptides searched for by MASCOT; (h) cellular functions based on literature database. Fr meant protein fragment based on 
UniProtKB database. 
 
 
 
Figure 6: Typical 2-DE protein profile of (A) MSC, (B) AC, and (C) cMSC. 
100 µg of protein cell lysate were conducted on 24 cm IPG strip (pH 3-10) 
and 12.5% SDS-PAGE. 2-DE gels were visualized via silver staining. The 
differentially expressed proteins studied are depicted on the gels. Gels 
were stained with silver nitrate and image analysis was performed using 
Nonlinear Progenesis SameSpot software. 
 
Protein Expression between Cell Types 
Differences in the protein expression of the six 
protein spots were subsequently evaluated in fold 
change between three groups (Table 3). For MSC and 
AC groups, all proteins except TAGLN2 were differ-
entially expressed (p<0.01). CFL1, ALDOA, TAGLN2 
and EF1-ALPHA were up-regulated in MSC while 
MYL6B and GAPD were highly expressed in AC. The 
expression of MYL6B and GAPD were higher in 
cMSC than MSC (p<0.01), whereas the remaining 
proteins (i.e CFL1, ALDOA, TAGLN2 and 
EF1-ALPHA) were higher in MSCs than cMSCs 
(p<0.01). All proteins except GAPD were differentially 
expressed between cMSC and AC (p<0.01). However, 
only CFL1 was more highly expressed in cMSC than 
the rest of the proteins (i.e MYL6B, GAPD, ALDOA, 
TAGLN2 and EF1-ALPHA).  
 
Table 3: Comparison of protein expression fold change and 
ANOVA p-value between two cell groups. MSC vs AC; cMSC vs 
MSC and cMSC vs AC.  
Spot No. MSC vs AC cMSC vs MSC cMSC vs AC 
Fold 
Change 
ANOVA 
(p) 
Fold 
Change 
ANOVA 
(p) 
Fold 
Change 
ANOVA 
(p) 
CFL1 +2.6 0.003 −2.0 0.001 +1.3 0.307 
MYL6B −7.3 0.001 +2.8 0.001 −2.6 0.001 
GAPD −6.9 0.001 +3.3 0.004 −2.1 0.115 
ALDOA +1.8 0.001 −2.8 0.001 −1.6 0.001 
TAGLN2 +1.6 0.105 −5.1 0.001 −3.3 0.001 
EF1-ALPHA +1.5 0.004 −5.0 0.001 −3.3 0.003 
p-values of less than 0.01 (p<0.01) were considered significant. 
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Discussion  
In this preliminary study, primary MSCs and 
ACs demonstrated significant differences in their 
protein profiles. Whilst it can be assumed that similar 
profiles to that of ACs should be expressed by chon-
drogenic MSCs, this was not observed in our present 
study, suggesting that cMSCs may not function ex-
actly the same way to native ACs. This has become the 
premise in which based on the differentially ex-
pressed protein profile, we hypothesize that cMSCs 
do not perform as expected in vivo [5]. There were six 
most differentially expressed proteins observed in 
between the ACs, MSCs and cMSCs. However, of 
these, only MYL6B, ALDOA, TAGLN2 and 
EF1-ALPHA were not highly modulated in cMSCs as 
compared to ACs. Further analyses of the data gained 
in this study revealed that these differentially ex-
pressed proteins from cMSCs were related to cyto-
skeletal, metabolic enzymes, and biosynthesis pro-
teins, which may have contributed to the ineffective-
ness of these differentiated cells in cartilage repair. 
In general, the actin cytoskeleton regulation of 
stem cell is essential for chondrogenesis [14] where 
TGF-β rapidly activates PI3K/Akt pathway towards 
the reorganization of actin filament and cell migration 
[15]. However, this study demonstrates that cofilin-1 
(CFL1), myosin light chain (MLC6B) and transgelin-2 
(TAGLN2) were highly modulated in MSC towards 
chondrogenic lineage in vitro. CFL1 enhances the rate 
of dissociation of actin microfilaments, which in turn 
affects the mechanical properties and extracellular 
matrix assembly of the cells [16, 17]. In contrary to 
CFL1, the expression level of MYL6B appears to be 
increasing in an ascending order from MSCs, cMSCs 
to ACs. In this study, cMSCs and ACs may have in-
dicated the occurrence of cell contraction during the 
remodelling of collagen-GAG extracellular matrix 
(ECM) and acto-myosin fibril [18, 19]. TGF-β has been 
reported to inhibit cofilin through non-Smad signal-
ling pathways by activating Rho GTPases, ROCK and 
Limk2, thus shifting towards actin polymerization 
[20, 21]. Our findings indicate that the complex inter-
actions of ECM molecules may modulate cell-ECM 
attachment, resulting in initiation of chondrogenesis 
and maintenance of the chondrogenic phenotype [22]. 
Although hydrogel contraction could be beneficial for 
the production of cartilaginous constructs using 
MSCs, it is postulated that the transgelin associated 
cell-seeded scaffolds contraction might possibly affect 
cell migration and proliferation, hence resulting in 
poorly functional chondrocytes. In this study, 
TAGLN2 was significantly down-regulated in cMSC 
(p<0.01). Absence of TAGLN2 has shown to increase 
the activity of Rho GTPase [23] that phosphorylates 
MYL6B and induces formation of stress fibres [24, 25]. 
The underlying mechanism behind the association of 
TAGLN2 down-regulation in cMSCs compared to the 
AC is unclear, therefore further comparative analysis 
may be required in order to provide further insights 
to the role of TAGLN2 in chondrogenesis. 
Activity of GAPD in cMSC and ACs has in-
creased three folds as compared to MSCs. Rocha et. al. 
(2012) reported similar outcome of which the cyto-
skeleton-related and metabolic-related protein were 
upregulated [26]. Increased expression of GAPD is 
associated with the synthesis and deposition of ECM 
molecules [27]. Cartilage ECM proteoglycans for-
mation is preceded by markedly increased activity of 
uridinediphosphoglucose dehydrogenase (UDPGD), 
which is directly associated with GAG synthesis, 
glucose-6-phosphate dehydrogenase, GAPD and suc-
cinate dehydrogenase [28]. In this study, ALDOA 
expression was lower in cMSCs than both the MSCs 
and ACs. ALDOA is a glycolytic enzyme for energy 
generation in chondrocytes, particularly marked at 
cell maturity [27]. Reduction of energy modulated by 
ALDOA may limit the ability of ACs to restore GAG 
matrices [28]. Recently, both GAPD and ALDOA have 
been found to interact with S100A1 and S100B pro-
teins that suppress hypertrophic differentiation and 
mineralization of chondrogenic cells [29].  
Elongation factor 1-alpha (EF1-alpha), a 
GTP-binding protein plays a central role in protein 
biosynthesis. In this study, this factor was found sig-
nificantly down-regulated in cMSC (p<0.01). 
EF1-alpha is a key regulator of various physiological 
processes, such as aging, proliferation, apoptosis, 
protein degradation and cytoskeletal rearrangement 
[30]. Phosphorylated EF1-alpha by type-I TGFβ re-
ceptor kinase at Serine 300 exerted a direct inhibitory 
on protein synthesis, therefore reducing cell prolifer-
ation [31]. Detailed molecular mechanism of this 
pathway remains unexplored. It was suggested that 
phosphorylated EF1-alpha represents a mechanism 
by which cell cycle is inhibited as a relative fast re-
sponse to TGF-β [31]. EF1-alpha also interacts with the 
cytoskeleton by binding and bundling with actin fil-
aments and microtubules [32, 33]. In this context, 
EF1-alpha functions in regulating the transport, an-
chorage and translation of mRNA on actin filaments 
that may be important in ACs [33]. 
It needs to be reminded that although the pre-
sent study has demonstrated some interesting results, 
certain limitations needs to be understood in order 
not to overstate the findings of the present study. In a 
study using animal as a reference of protein differ-
ences, it is worth noting that several protein differ-
ences may exist in other species, especially in human. 
It has been previously demonstrated that cartilage 
gene expressions and characteristics are species spe-
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cific, and therefore may vary among the different 
species [34, 35]. This is important when having to 
translate the findings clinically. Nevertheless, healthy 
human donor matched MSCs and ACs samples under 
a well-controlled environment are not usually availa-
ble and therefore not feasible to be used in any labor-
atory study. However, in comparison to what is 
available today, the present study has its positive 
points as most studies of similar nature are limited to 
immortalized cell line such as C3H10T1/2, which 
many will agree by itself express aberrant proteins [7, 
36]. While the present study has suggested that any 
disruption in the cytoskeletal, metabolic enzymes, 
and biosynthesis proteins functions may be the cause 
for the ineffectiveness of cMSCs, this still needs to be 
proven in more specifically experimental designs.  
Conclusions 
In this study, distinct differences in the global 
protein expressions were identified between ACs, 
MSCs and cMSCs. Of these differentially expressed 
proteins, MYL6B, ALDOA, TAGLN2 and 
EF1-ALPHA were not as highly modulated during 
MSC chondrogenesis as compared to ACs. These dif-
ferences may have been the contributing factors to the 
ineffectiveness of cMSCs in the cartilage repair. 
However, this needs to be demonstrated and sup-
ported by data obtained from more rigorously de-
signed studies. 
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